FDA Approves Nirsevimab, a New Treatment to Protect Newborns from Respiratory Syncytial Virus (RSV)
Dubai, United Arab Emirates (CNN) — This fall, parents and pediatricians will have a new option to protect children from a virus that attacks the lungs and is the leading cause of hospitalizations for infants under one year of age in the United States each year. On Monday, the US Food and Drug Administration approved … Read more